Breaking News Instant updates and real-time market news.

H

Hyatt

$80.63

0.09 (0.11%)

11:07
02/15/18
02/15
11:07
02/15/18
11:07

Hyatt sees FY18 adjusted EBITDA $805M-$825M

The company provided the following information for the 2018 fiscal year: Net income is expected to be approximately $176M to $215M. Adjusted EBITDA is expected to be approximately $805M to $825M. These estimates also include a favorable impact from foreign currency of approximately $0 to $5M. Comparable systemwide RevPAR is expected to increase approximately 1% to 3%, as compared to fiscal year 2017. Adjusted selling, general, and administrative expenses are expected to be approximately $300M. This excludes approximately $35M to $36M of stock-based compensation expense and any potential expenses related to benefit programs funded through rabbi trusts. Capital expenditures are expected to be approximately $350M. Depreciation and amortization expense is expected to be approximately $367M to $371M. Interest expense is expected to be approximately $75M to $76M. Other income, net is expected to be negatively impacted by approximately $65M to $75M related to performance guarantee expense for the four managed hotels in France. The effective tax rate is expected to be approximately 27% to 31%, reflecting estimated impacts from recent U.S. tax reform. The company expects to grow units, on a net rooms basis, by approximately 6.0% to 6.5%, reflecting approximately 60 new hotel openings. The company expects to return at least $300M to shareholders through a combination of cash dividends on its common stock and share repurchases. The above does not reflect anticipated changes resulting from the adoption of the new revenue recognition standard in 2018. The company is in the process of finalizing the adoption impact and restatement of prior year results. As previously disclosed, the most material non-cash impact to Adjusted EBITDA relates to the change in accounting for deferred gains which would result in a reduction of $25M in 2017 and an anticipated reduction of approximately $31M in 2018.

  • 15

    Feb

  • 25

    Mar

H Hyatt
$80.63

0.09 (0.11%)

12/21/17
WOLF
12/21/17
UPGRADE
WOLF
Outperform
Hyatt upgraded to Outperform from Peer Perform at Wolfe Research
Wolfe Research upgraded Hyatt to Outperform with a $90 price target saying shares are "cheap" especially after tax reform savings.
01/03/18
DBAB
01/03/18
NO CHANGE
Target $90
DBAB
Buy
Deutsche neutral on Lodging space into 2018, continues to favor Hilton
Deutsche Bank analyst Carlo Santarelli attributes the 2017 rally in Lodging stocks to a combination of favorable sector rotation, optimism around tax reform, new branded credit card deals and an acceleration in the return of capital. With the cycle one year closer to a natural conclusion and tax reform is complete, the analyst believes sector rotation is more likely to be a headwind than a tailwind in 2018. As such, he's taking a neutral approach to the group heading into 2018, while continuing to favor Hilton (HLT). Santarelli raised his price target for the Hilton to $90 from $79, for Choice Hotels (CHH) to $80 from $74, for Hyatt (H) to $78 from $72 and for Marriott (MAR) to $136 from $124.
01/08/18
RAJA
01/08/18
UPGRADE
RAJA
Outperform
Hyatt upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst William Crow upgraded Hyatt to Outperform and established an $82 price target. The analyst said management is committed to an asset-light model through the sale of $1.5B in owned real estate during the next couple years, there is a material valuation gap versus peers, robust new unit growth and pipeline, and the tax credit benefit's Hyatt slightly more than peers.
01/08/18
BOFA
01/08/18
NO CHANGE
BOFA
Buy
Hyatt added to US 1 List at BofA/Merrill

TODAY'S FREE FLY STORIES

09:45
12/17/18
12/17
09:45
12/17/18
09:45
General news
FOMC Checklist: »

FOMC Checklist: The FOMC…

09:45
12/17/18
12/17
09:45
12/17/18
09:45
General news
Housing Market Index to be reported at 10:00 »

December Housing Market…

CMLS

Cumulus Media

$10.75

(0.00%)

09:40
12/17/18
12/17
09:40
12/17/18
09:40
Upgrade
Cumulus Media rating change  »

Cumulus Media upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBD

Banco Bradesco

$9.75

(0.00%)

, NOK

Nokia

$5.94

(0.00%)

09:40
12/17/18
12/17
09:40
12/17/18
09:40
Options
Unusually active option classes on open December 17th »

Unusual total active…

BBD

Banco Bradesco

$9.75

(0.00%)

NOK

Nokia

$5.94

(0.00%)

NIO

NIO Inc.

$7.67

(0.00%)

T

AT&T

$30.24

(0.00%)

VXX

iPath S&P 500 VIX Short-Term Futures

$40.53

(0.00%)

DIA

Diamonds Fund ETF

$241.50

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 20

    Mar

JNJ

Johnson & Johnson

$132.86

-14.94 (-10.11%)

09:39
12/17/18
12/17
09:39
12/17/18
09:39
Technical Analysis
Technical Take: Johnson & Johnson extends recent fall »

Shares are down over 3.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

ZEAL

Zealand Pharma

$13.19

(0.00%)

09:39
12/17/18
12/17
09:39
12/17/18
09:39
Downgrade
Zealand Pharma rating change  »

Zealand Pharma downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:37
12/17/18
12/17
09:37
12/17/18
09:37
General news
Friday selloff spills into new week »

Stock futures fell during…

ALTM

Altus Midstream Company

$8.72

-0.71 (-7.53%)

09:35
12/17/18
12/17
09:35
12/17/18
09:35
Hot Stocks
Breaking Hot Stocks news story on Altus Midstream Company »

Altus Midstream Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMK

Aramark

$32.07

-0.63 (-1.93%)

09:33
12/17/18
12/17
09:33
12/17/18
09:33
Periodicals
Breaking Periodicals news story on Aramark »

Aramark mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$56.32

-0.28 (-0.49%)

09:30
12/17/18
12/17
09:30
12/17/18
09:30
Upgrade
Carnival rating change  »

Carnival upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

CNC

Centene

$127.55

-5.3 (-3.99%)

09:30
12/17/18
12/17
09:30
12/17/18
09:30
Recommendations
Centene analyst commentary  »

BMO says Centene's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

ALTM

Altus Midstream Company

$8.72

-0.71 (-7.53%)

09:30
12/17/18
12/17
09:30
12/17/18
09:30
Hot Stocks
Breaking Hot Stocks news story on Altus Midstream Company »

Altus Midstream Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$365.69

-11.17 (-2.96%)

, AAPL

Apple

$165.48

-5.45 (-3.19%)

09:26
12/17/18
12/17
09:26
12/17/18
09:26
Periodicals
Designer Andrew Kim departs Tesla to join Apple, The Verge reports »

Tesla (TSLA) senior…

TSLA

Tesla

$365.69

-11.17 (-2.96%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTSX

Point 360

$0.00

(0.00%)

09:25
12/17/18
12/17
09:25
12/17/18
09:25
Hot Stocks
Court approves Point 360 second amended disclosure statement »

Point.360 announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.49

0.1 (0.41%)

09:24
12/17/18
12/17
09:24
12/17/18
09:24
Hot Stocks
Bank of America reports November card write-offs 2.68% vs. 2.43% last month »

Reports November 30-plus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

IBTX

Independent Bank

$47.72

-1.6 (-3.24%)

, GBNK

Guaranty Bancorp

$21.44

-0.65 (-2.94%)

09:24
12/17/18
12/17
09:24
12/17/18
09:24
Hot Stocks
Independent Bank receives regulatory approval for Guaranty Bancorp merger »

Independent Bank (IBTX)…

IBTX

Independent Bank

$47.72

-1.6 (-3.24%)

GBNK

Guaranty Bancorp

$21.44

-0.65 (-2.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

09:22
12/17/18
12/17
09:22
12/17/18
09:22
Conference/Events
UBS retail analyst to hold an analyst/industry conference call »

Retail Analyst Sole…

MDT

Medtronic

$93.78

-1.7 (-1.78%)

09:22
12/17/18
12/17
09:22
12/17/18
09:22
Hot Stocks
Medtronic announces FDA approval of InterStim programmer »

Medtronic announced FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$24.78

0.8 (3.34%)

09:21
12/17/18
12/17
09:21
12/17/18
09:21
Recommendations
Smartsheet analyst commentary  »

William Blair remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

SWGAY

Swatch Group

$0.00

(0.00%)

09:20
12/17/18
12/17
09:20
12/17/18
09:20
Downgrade
Swatch Group rating change  »

Swatch Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:20
12/17/18
12/17
09:20
12/17/18
09:20
General news
U.S. equities continue to backtrack »

U.S. equities continue to…

GNUS

Genius Brands

$2.38

(0.00%)

09:19
12/17/18
12/17
09:19
12/17/18
09:19
Hot Stocks
Genius Brands licenses rights to Gershwin Entertainment for Rainbow Rangers live »

Genius Brands new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEN

Zendesk

$59.93

-1.26 (-2.06%)

09:19
12/17/18
12/17
09:19
12/17/18
09:19
Recommendations
Zendesk analyst commentary  »

Zendesk shares can offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

NTRP

Neurotrope

$4.08

-0.18 (-4.23%)

09:18
12/17/18
12/17
09:18
12/17/18
09:18
Syndicate
Neurotrope announces $22.5M registered direct offering »

Neurotrope announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
12/17/18
12/17
09:18
12/17/18
09:18
Options
Overnight activity included 611 trades in SPX and 21 trades in VIX »

611 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.